查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2082561

一次性生物製程市場：2026-2032年全球市場預測（按產品、工作流程階段、生物製程方法、一次性子組件、製造流程、應用和最終用戶分類）

Single-use Bioprocessing Market by Offering, Workflow Stage, Bioprocess Mode, Single-use Subassemblies, Manufacturing Processes, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，一次性生物製程市場將成長至 597.7 億美元，複合年成長率為 16.26%。

主要市場統計數據
基準年 2025 208.1億美元
預計年份：2026年 241.1億美元
預測年份 2032 597.7億美元
複合年成長率 (%) 16.26%

一次性生物製程已從一種小眾生產方法轉變為生物製藥、疫苗、生物相似藥和先進療法領域的主流操作模式。一次性生物反應器、生物袋、管路組件、連接器、過濾系統、無菌取樣技術和一次性感測器減輕了清洗驗證的負擔，縮短了換型時間，並支援GMP環境下的封閉式製程。

該產業的發展受到單株抗體、mRNA平台以及細胞和基因療法的全球擴張，以及上游和下游製程的日益複雜化的影響。注射用水、就地清洗（CIP）和原位蒸氣清洗（SIP）基礎設施的需求，以及交叉污染風險顯著降低的現狀，也推動了這項技術的應用。同時，買家仍在密切關注萃取物和洗脫液、樹脂安全性、供應商冗餘、顆粒控制和塑膠廢棄物管理等方面的問題。

產業的變革性變化

一次性生物製程的格局正朝著模組化、多產品和數位化互聯的設施方向轉變。製造商擴大將一次性生物反應器、層析法分離裝置、無菌轉移系統、一次性混合器、深度過濾和自動化平台相結合，以提高宣傳活動的柔軟性並縮短設施建設時間。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過提升製程理解、偏差檢測和生產力計畫，進一步增強了一次性生物製程的價值。當應用於經過驗證的、資料整合的品質系統時，AI 驅動的分析可以支援生物反應器控制、預測性維護、原料需求預測、目視檢查、電子批次記錄審核和製程監控。

對關鍵區域的洞察

隨著中國、印度、日本、韓國、新加坡和澳洲不斷擴大其生物製藥、生物相似藥、疫苗和先進療法的生產能力，亞太地區的戰略重要性日益凸顯。該地區受益於蓬勃發展的合約研發生產（CDMO）市場、公共衛生領域的投資、高素質的生物製程人才以及成本效益高的生產生態系統，但企業必須應對跨市場的供應商合格、樹脂可追溯性、低溫運輸可靠性以及監管協調等問題。

關鍵群體特定見解

東協市場在一次性生物製程領域的重要性日益凸顯。隨著新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國建構生物技術、疫苗和製藥生產生態系統，東協市場的重要性與日俱增。該地區的優勢在於其能夠透過區域間貿易合作、不斷成長的醫療保健需求、政府對生命科學投資的支持以及靈活模組化的生物製程基礎設施，滿足臨床階段和商業化生產的需求。

主要國家的概況

美國在生物製藥創新、合約研發生產能力、監管科學以​​及細胞和基因療法的商業化方面處於主導地位。同時，加拿大受益於疫苗投資、學術研究的實用化以及國內生物製造能力的擴張。墨西哥正透過北美供應鏈和近岸外包策略加強其製藥製造合作，而巴西憑藉著疫苗生產能力和對生物相似藥的需求，仍然是拉丁美洲最重要的生物製藥和公共衛生產品製造市場。

為行業領導者提供的實用建議

產業領導者應優先考慮關鍵一次性組件、薄膜、過濾器、連接器、管材、包裝袋和感測器的雙源採購策略。供應商合格不僅應包括價格，還應包括樹脂可追溯性、完善的變更通知機制、萃取物/浸出物控制、顆粒物管理、業務永續營運計劃以及區域物流韌性。

調查方法

本執行摘要基於二手研究，參考了公開認可的資訊來源和行業標準，包括FDA、EMA、WHO、ICH、USP和ISO等機構的監管指南，以及與一次性系統相關的藥典框架。此外，本摘要還考慮了行業實踐、GMP要求、生物製程組織發布的技術轉移指南，以及生物製藥、疫苗、生物相似藥和先進療法的技術應用記錄。

結論

一次性生物製程正成為生物製造的核心要素，它具有更高的柔軟性、擴充性和污染控制能力。隨著生物製藥產品線的多樣化，以及製造商對快速設施部署、更小的宣傳活動週期、更少的清潔負擔和更高的多產品響應能力的需求不斷成長，一次性生物製程的作用也日益凸顯。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 一次性生物製程市場：依產品/服務分類

  • 各個組件
    • 袋子和容器
    • 連接器
    • 過濾和分離設備
    • 泵浦和流量控制
    • 採樣裝置及配件
    • 感測器和探頭
    • 管道
      • 聚乙烯（PE）
      • 聚丙烯（PP）
      • 聚氯乙烯（PVC）
      • 矽酮
  • 一次性子組件
    • 生物反應器/製程組件
    • 培養基轉移組件
    • 採樣組件
    • 管路組件/歧管

第8章 一次性生物製程市場：依工作流程階段分類

  • 下游加工
  • 填充和表面處理工程
  • 品管與分析
  • 上游工程

第9章 一次性生物製程市場：依生物製程方法分類

  • 批次
  • 聯邦批次
  • 灌注

第10章 一次性生物製程市場：以一次性子組件分類

  • 無菌轉移套裝
  • 填充子組件
  • 歧管組件
  • 取樣子組件
  • 管組件

第11章 一次性生物製程市場：依製造流程分類

  • 3D列印
  • 黏附
  • 吹塑成型
  • 擠壓
  • 射出成型
  • 包覆成型
  • 射頻焊接
  • 熱成型
  • 超音波焊接

第12章 一次性生物製程市場：依應用領域分類

  • 無菌灌裝
  • 細胞培養
  • 過濾
  • 攪拌
  • 純化
  • 取樣
  • 貯存

第13章 一次性生物製程市場：依最終用戶分類

  • 學術研究機構
  • 契約製造組織（CMO）和受託研究機構（CRO）
  • 製藥和生物技術公司

第14章 一次性生物製程市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 一次性生物製程市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 一次性生物製程市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • AdvantaPure by NewAge Industries
  • Agilitech
  • Aseptic Group
  • Avantor, Inc.
  • Bionet Servicios Tecnicos SL
  • BioPharma Dynamics Ltd.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Compagnie de Saint-Gobain
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Eppendorf SE
  • Foxx Life Sciences
  • Freudenberg Group
  • Getinge AB
  • Kuehne+Nagel International AG
  • Lonza Group AG Ltd.
  • Meissner Corporation
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • Parker-Hannifin Corporation
  • PBS Biotech, Inc.
  • PharmNXT Biotech
  • PSG Dover by Dover Corporation
  • Repligen Corporation
  • SaniSure
  • Sartorius AG
  • Satake Multimix Corporation
  • Single Use Support GmbH
  • Tekni-Plex, Inc.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
Product Code: MRR-431752EA4978

The Single-use Bioprocessing Market is projected to grow by USD 59.77 billion at a CAGR of 16.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.81 billion
Estimated Year [2026] USD 24.11 billion
Forecast Year [2032] USD 59.77 billion
CAGR (%) 16.26%

Single-use bioprocessing has moved from a niche manufacturing option to a mainstream operating model for biologics, vaccines, biosimilars, and advanced therapies. Disposable bioreactors, bags, tubing assemblies, connectors, filtration systems, sterile sampling technologies, and single-use sensors reduce cleaning validation burden, shorten changeover time, and support closed processing in GMP environments.

The industry is being shaped by the global expansion of monoclonal antibodies, mRNA platforms, cell and gene therapies, and intensified upstream and downstream processing. Adoption is also supported by documented reductions in water-for-injection demand, clean-in-place and steam-in-place infrastructure, and cross-contamination risk, while buyers continue to scrutinize extractables and leachables, resin security, supplier redundancy, particulate control, and plastic waste management.

Transformative Shifts in the Landscape

The single-use bioprocessing landscape is shifting toward modular, multiproduct, and digitally connected facilities. Manufacturers are increasingly combining single-use bioreactors, chromatography skids, sterile transfer systems, single-use mixers, depth filtration, and automation platforms to improve campaign flexibility and reduce facility buildout time.

A second major shift is the movement from open or semi-open workflows to closed, integrated processing. This transition is especially relevant for high-value biologics and personalized therapies where sterility assurance, rapid batch release, and manufacturing agility are critical. Standardization initiatives from industry groups, pharmacopoeias, and regulators are also improving confidence in materials characterization, component qualification, extractables and leachables testing, and supplier change control.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of single-use bioprocessing by improving process understanding, deviation detection, and capacity planning. AI-enabled analytics can support bioreactor control, predictive maintenance, raw-material forecasting, visual inspection, electronic batch record review, and process monitoring when implemented within validated, data-integrity-compliant quality systems.

The strongest near-term impact is in hybrid decision support rather than fully autonomous manufacturing. Digital twins, multivariate analysis, and machine learning models can help teams link sensor data, media performance, mixing conditions, cell-culture behavior, and filtration performance to critical quality attributes. However, adoption depends on robust model governance, audit trails, cybersecurity, human oversight, and alignment with FDA, EMA, ICH Q9, ICH Q10, ICH Q12, and GAMP principles.

Key Regional Insights

Asia-Pacific is gaining strategic importance as China, India, Japan, South Korea, Singapore, and Australia expand biologics, biosimilar, vaccine, and advanced therapy manufacturing capacity. The region benefits from contract development and manufacturing momentum, public health investment, skilled bioprocessing talent, and cost-efficient production ecosystems, although firms must manage supplier qualification, resin traceability, cold-chain reliability, and regulatory harmonization across diverse markets.

North America remains a leading demand center due to the United States and Canada's concentration of biologics developers, CDMOs, cell therapy innovators, clinical trial infrastructure, and advanced manufacturing programs. Latin America, led by Brazil and Mexico, is adopting single-use technologies to strengthen vaccine resilience, public-sector biologics production, and biosimilar manufacturing. Europe maintains strong demand through Germany, France, Italy, Spain, the United Kingdom, and broader European quality expectations, with adoption shaped by EMA oversight, EU GMP expectations, advanced therapy activity, and rising sustainability scrutiny around disposable plastics.

The Middle East is emerging through GCC investments in pharmaceutical localization, with Saudi Arabia and the United Arab Emirates prioritizing healthcare security, vaccine access, and biomanufacturing capability. Africa is earlier in adoption but increasingly relevant as regional vaccine manufacturing, fill-finish capacity, workforce development, and technology-transfer initiatives develop in markets such as South Africa, Egypt, Rwanda, Senegal, and Morocco.

Key Group Insights

ASEAN markets are increasingly relevant for single-use bioprocessing because Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines are building biotechnology, vaccine, and pharmaceutical manufacturing ecosystems. The group's advantage lies in regional trade connectivity, growing healthcare demand, government support for life sciences investment, and the ability to serve both clinical-stage and commercial manufacturing needs through flexible, modular bioprocessing infrastructure.

The GCC is using healthcare diversification strategies to build local production capacity, reduce import dependency, and support vaccine and biologics access, while the European Union provides a highly regulated and innovation-oriented environment shaped by EMA oversight, EU GMP expectations, pharmacovigilance discipline, and sustainability policy. BRICS countries are important because Brazil, Russia, India, China, and South Africa combine large patient populations with rising biopharmaceutical manufacturing ambitions, biosimilar activity, public health programs, and policy support for localized production.

G7 countries remain central to technology development, regulatory precedent, advanced therapy commercialization, and high-value biologics manufacturing. NATO members, many of which overlap with G7 and EU economies, also influence biomanufacturing resilience through supply-chain security, pandemic preparedness, strategic stockpiling, dual-use manufacturing readiness, and defense-adjacent medical countermeasure programs.

Key Country Insights

The United States leads in biologics innovation, CDMO capacity, regulatory science, and cell and gene therapy commercialization, while Canada benefits from vaccine investments, academic translation, and growing domestic biomanufacturing capability. Mexico is strengthening pharmaceutical manufacturing links with North American supply chains and nearshoring strategies, and Brazil remains Latin America's most important biologics and public-health production market, supported by vaccine capabilities and biosimilar demand.

In Europe, the United Kingdom supports advanced therapy development, clinical manufacturing, and regulatory flexibility, Germany anchors engineering, automation, high-specification bioprocess equipment demand, and biologics manufacturing, and France is expanding vaccine and biologics capacity. Italy and Spain are important for contract manufacturing, injectable drug production, and sterile processing, while Russia maintains localized biologics ambitions despite geopolitical, financing, and supply constraints affecting access to advanced components and validation support.

In Asia-Pacific, China has scaled biologics and biosimilar development rapidly with expanding domestic manufacturing capability, India combines vaccine leadership with biosimilar production and CDMO growth, and Japan emphasizes quality, automation, process control, and specialty biologics. South Korea has become a global biologics manufacturing hub with strong large-scale biomanufacturing capabilities, and Australia supports clinical-stage biomanufacturing, translational research, advanced therapy development, and regional supply resilience.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a dual-sourcing strategy for critical single-use assemblies, films, filters, connectors, tubing, bags, and sensors. Supplier qualification must extend beyond price to include resin traceability, change-notification discipline, extractables and leachables packages, particulate controls, business continuity planning, and regional logistics resilience.

Manufacturers should also build quality-by-design frameworks that integrate closed processing, standardized assemblies, validated automation, operator training, and real-time data capture. Sustainability should be addressed through lifecycle assessment, waste segregation, take-back programs where available, responsible incineration or recycling routes where technically feasible, and facility designs that quantify reductions in water, energy, cleaning chemicals, and cleaning validation effort.

Research Methodology

This executive summary is developed using secondary research grounded in recognized public sources and industry standards, including regulatory guidance from FDA, EMA, WHO, ICH, USP, ISO, and pharmacopeial frameworks relevant to single-use systems. It also considers published industry practices from bioprocessing associations, GMP expectations, technology-transfer guidance, and documented technology adoption across biologics, vaccines, biosimilars, and advanced therapies.

The analysis applies a triangulated approach that reviews demand drivers, manufacturing trends, regional policy signals, supply-chain considerations, regulatory expectations, and technology maturity. Insights are validated against observable industry behavior, including capacity expansions, CDMO strategies, quality-system requirements, and the operational characteristics of single-use bioreactors, filtration, mixing, storage, aseptic sampling, sterile connectors, and closed transfer systems.

Conclusion

Single-use bioprocessing is becoming a core enabler of flexible, scalable, and contamination-controlled biomanufacturing. Its role is expanding as biologics pipelines diversify and manufacturers seek faster facility deployment, smaller campaign footprints, reduced cleaning burden, and improved multiproduct agility.

The next phase of industry adoption will depend on disciplined quality management, resilient supplier ecosystems, AI-enabled process intelligence, and credible sustainability practices. Organizations that combine single-use platforms with validated automation, regional supply strategies, robust regulatory documentation, and lifecycle-based waste management will be best positioned to capture long-term operational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Single-use Bioprocessing Market, by Offering

  • 7.1. Individual Components
    • 7.1.1. Bags & Containers
    • 7.1.2. Connectors
    • 7.1.3. Filtration & Separation Devices
    • 7.1.4. Pumps & Flow Control
    • 7.1.5. Sampling Devices & Accessories
    • 7.1.6. Sensors & Probes
    • 7.1.7. Tubing
      • 7.1.7.1. Polyethylene (PE)
      • 7.1.7.2. Polypropylene (PP)
      • 7.1.7.3. Polyvinyl Chloride (PVC)
      • 7.1.7.4. Silicone
  • 7.2. Single-Use Subassemblies
    • 7.2.1. Bioreactor / Process Assemblies
    • 7.2.2. Media Transfer Assemblies
    • 7.2.3. Sampling Assemblies
    • 7.2.4. Tubing Assemblies / Manifolds

8. Single-use Bioprocessing Market, by Workflow Stage

  • 8.1. Downstream Processing
  • 8.2. Fill-Finish Operations
  • 8.3. Quality Control & Analytics
  • 8.4. Upstream Processing

9. Single-use Bioprocessing Market, by Bioprocess Mode

  • 9.1. Batch
  • 9.2. Fed-Batch
  • 9.3. Perfusion

10. Single-use Bioprocessing Market, by Single-use Subassemblies

  • 10.1. Aseptic Transfer Sets
  • 10.2. Filling Subassemblies
  • 10.3. Manifold Assemblies
  • 10.4. Sampling Subassemblies
  • 10.5. Tubing Assemblies

11. Single-use Bioprocessing Market, by Manufacturing Processes

  • 11.1. 3D Printing
  • 11.2. Adhesive Bonding
  • 11.3. Blow Molding
  • 11.4. Extrusion
  • 11.5. Injection Molding
  • 11.6. Overmolding
  • 11.7. RF Welding
  • 11.8. Thermoforming
  • 11.9. Ultrasonic Welding

12. Single-use Bioprocessing Market, by Application

  • 12.1. Aseptic Filling
  • 12.2. Cell Culture
  • 12.3. Filtration
  • 12.4. Mixing
  • 12.5. Purification
  • 12.6. Sampling
  • 12.7. Storage

13. Single-use Bioprocessing Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Contract Manufacturing Organizations & Contract Research Organizations
  • 13.3. Pharmaceutical & Biotechnology Companies

14. Single-use Bioprocessing Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Single-use Bioprocessing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Single-use Bioprocessing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. AdvantaPure by NewAge Industries
  • 18.2. Agilitech
  • 18.3. Aseptic Group
  • 18.4. Avantor, Inc.
  • 18.5. Bionet Servicios Tecnicos SL
  • 18.6. BioPharma Dynamics Ltd.
  • 18.7. CellBios Healthcare & Lifesciences Pvt. Ltd.
  • 18.8. Compagnie de Saint-Gobain
  • 18.9. Corning Incorporated
  • 18.10. Cytiva by Danaher Corporation
  • 18.11. Entegris, Inc.
  • 18.12. Eppendorf SE
  • 18.13. Foxx Life Sciences
  • 18.14. Freudenberg Group
  • 18.15. Getinge AB
  • 18.16. Kuehne + Nagel International AG
  • 18.17. Lonza Group AG Ltd.
  • 18.18. Meissner Corporation
  • 18.19. Merck KGaA
  • 18.20. Mettler-Toledo International Inc.
  • 18.21. Parker-Hannifin Corporation
  • 18.22. PBS Biotech, Inc.
  • 18.23. PharmNXT Biotech
  • 18.24. PSG Dover by Dover Corporation
  • 18.25. Repligen Corporation
  • 18.26. SaniSure
  • 18.27. Sartorius AG
  • 18.28. Satake Multimix Corporation
  • 18.29. Single Use Support GmbH
  • 18.30. Tekni-Plex, Inc.
  • 18.31. Thermo Fisher Scientific Inc.
  • 18.32. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INDIVIDUAL COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BAGS & CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FILTRATION & SEPARATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PUMPS & FLOW CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SAMPLING DEVICES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SENSORS & PROBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SENSORS & PROBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SENSORS & PROBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TUBING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TUBING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TUBING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYETHYLENE (PE) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYPROPYLENE (PP) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYVINYL CHLORIDE (PVC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SILICONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOREACTOR / PROCESS ASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDIA TRANSFER ASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SAMPLING ASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TUBING ASSEMBLIES / MANIFOLDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FILL-FINISH OPERATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL QUALITY CONTROL & ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FED-BATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FED-BATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FED-BATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ASEPTIC TRANSFER SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FILLING SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MANIFOLD ASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SAMPLING SUBASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TUBING ASSEMBLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL 3D PRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL 3D PRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL 3D PRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ADHESIVE BONDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ADHESIVE BONDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ADHESIVE BONDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOW MOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOW MOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOW MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EXTRUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INJECTION MOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OVERMOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OVERMOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OVERMOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RF WELDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RF WELDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RF WELDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL THERMOFORMING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL THERMOFORMING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL THERMOFORMING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ULTRASONIC WELDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ASEPTIC FILLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ASEPTIC FILLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ASEPTIC FILLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MIXING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MIXING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MIXING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PURIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PURIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SAMPLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SAMPLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SAMPLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL STORAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL STORAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL STORAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 234. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 236. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 237. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 240. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 241. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 267. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 268. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 269. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 270. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 273. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 274. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 278. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 279. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 280. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 281. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 283. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 284. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 285. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 345. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 346. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 347. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 348. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)